Style Challenge Accepted: Step & Repeat Returns to TikTok With Host Celebrity Stylist Zadrian Smith
2.6.2022 23:53:00 EEST | Business Wire | Press release
Calling all models—your virtual runway awaits! Step & Repeat, the first ever style and fashion competition launched on TikTok, returns for season two on June 7. Last year, Glamhive and Mary Kay Global Design Studio unveiled the fashion reality contest that reached millions of users worldwide. Now, the four-week style challenge is back and promises to be the fashion extravaganza we’ve all been waiting for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005868/en/
Zadrian Smith, Celebrity Stylist (Photo: Mary Kay Inc.)
Celebrity Stylist Zadrian Smith (clients include: Ariana DeBose, Naama Preis, Naomi Scott) hosts Step & Repeat with three judges and industry favorites: celebrity stylist Tara Swennen (clients include: Kristen Stewart, Matthew McConaughey), celebrity stylist Nicole Chavez (clients include: Kristen Bell, Jessica Simpson), and celebrity hairstylist Larry Sims (clients include: Victoria Beckham, Queen Latifah).
Each week, host Zadrian Smith will announce a theme-based challenge for TikTok users to showcase their creativity through wardrobe, makeup, and hair. The show’s celebrity judges will duet the best looks from around the world and cast their votes for winners in each category. Participants are asked to incorporate the show’s custom sound, “Step & Repeat,” and hashtags, #stepandrepeat, #glamhive, and #marykay to enter their video into the competition. For each challenge there will be three winners, hand-picked by the judges, who will receive a cash prize plus an hour one-on-one meeting with an industry mentor.
At the end of the four weeks, Step & Repeat will announce one overall winner for each category, crowning them the very best in wardrobe, makeup, and hair based on entries from all over the world. TikTok is the place for anyone with talent and a creative voice to share their gift on a global scale. Step & Repeat is the platform that gives you the opportunity to be seen and celebrated.
Zadrian Smith, Celebrity Stylist (Host)
“As my career has progressed as a Global Fashion Director and Journalist, I’ve wanted to prioritize working to create a more equitable fashion industry. It’s not always easy or comfortable work, but any opportunity that I can provide to help other people interested in the industry with a step up - that’s a conversation that I want to be a part of.”
Tara Swennen, Celebrity Stylist (Judge)
“There are so many people with incredible creative talent and Step & Repeat gives them a place to shine. I'm very excited to see the looks that people from all over the world will be debuting on our social media runway!”
Nicole Chavez, Celebrity Stylist (Judge)
“Season One of ‘Step & Repeat’ absolutely inspired me. I was excited every week to see what the contestants created and blown away by the range of talent. I can't wait to see the results of our challenges in Season Two!”
Larry Sims, Celebrity Hairstylist (Judge)
“It takes courage, confidence, & creativity to show the world why you're an amazing artist. I’m excited to see the contestants bring it!”
Stephanie Sprangers, Founder and CEO of Glamhive
“Our vision for ‘Step & Repeat’ was to create a fast-paced style competition that encompassed creativity, inclusivity, connections, and recognition, and Season One delivered in spades. Now, for the second time, the industry's best are coming together to welcome and encourage style talent from around the world. We're so excited to see what happens in Season Two.”
Step & Repeat Mentors:
- Claire Sulmers, CEO & Founder of Fashion Bomb Daily
- Adam Drawas, Owner, Walker Drawas PR
- Quentin Thrash, Bespoke Designer & Celebrity Barber
- Brian Underwood, Fashion Director, Women’s Health
- Mandi Line, Costume Designer (The Bold Type, Pretty Little Liars, Shameless)
- Pandora Amoratis, Style Director, US Daily Mail
- Sheridan Ward, Celebrity Hairstylist
- Shatora Adrell, Fashion Designer and Stylist
- Carrie Colbert, Founding & General Partner, Curate Capital
- Quinn Murphy, Celebrity Makeup Artist
- Alexis Bennett, Editor, Vogue
- Gilda Koral Flora, Founder, Koral Communications
- Christian Wood, Celebrity Hairstylist
For more information, visit https://www.glamhive.com/tiktok
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous. The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005868/en/
Contact information
Stephanie Sprangers
CEO, Glamhive
stephanie@glamhive.com
+1.206.851.0446
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 08:30:00 EEST | Press release
SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
